secwatch / observer
8-K filed February 10, 2025, 6:59 PM ET ticker SYK CIK 0000310764
debt confidence high sentiment neutral materiality 0.65

STRYKER CORP (SYK): debt financing — Stryker issues $3B in notes; $1.8B earmarked for Inari Medical acquisition

STRYKER CORP

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

STRYKER CORP incurred senior notes of $800,000,000 with Public at 4.850% maturing February 10, 2030.

Instrument
senior notes
Principal
$800,000,000
Counterparty
Public
Rate
4.850%
Maturity
February 10, 2030
Event
incurrence
Exact text from the filing
On February 10, 2025, Stryker Corporation (the “Company”) completed a public offering (the “Offering”) of $500,000,000 aggregate principal amount of its 4.550% Notes due 2027 (the “2027 Notes”), $700,000,000 aggregate principal amount of its 4.700% Notes due 2028 (the “2028 Notes”), $800,000,000 aggregate principal amount of its 4.850% Notes due 2030 (the “2030 Notes”) and $1,000,000,000 aggregate principal amount of its 5.200% Notes due 2035 (the “2035 Notes” and, together with the 2027 Notes, the 2028 Notes and the 2030 Notes, the “Notes”).
View on SEC.gov
Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

STRYKER CORP incurred senior notes of $1,000,000,000 with Public at 5.200% maturing February 10, 2035.

Instrument
senior notes
Principal
$1,000,000,000
Counterparty
Public
Rate
5.200%
Maturity
February 10, 2035
Event
incurrence
Exact text from the filing
On February 10, 2025, Stryker Corporation (the “Company”) completed a public offering (the “Offering”) of $500,000,000 aggregate principal amount of its 4.550% Notes due 2027 (the “2027 Notes”), $700,000,000 aggregate principal amount of its 4.700% Notes due 2028 (the “2028 Notes”), $800,000,000 aggregate principal amount of its 4.850% Notes due 2030 (the “2030 Notes”) and $1,000,000,000 aggregate principal amount of its 5.200% Notes due 2035 (the “2035 Notes” and, together with the 2027 Notes, the 2028 Notes and the 2030 Notes, the “Notes”).
View on SEC.gov
Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

STRYKER CORP incurred senior notes of $700,000,000 with Public at 4.700% maturing February 10, 2028.

Instrument
senior notes
Principal
$700,000,000
Counterparty
Public
Rate
4.700%
Maturity
February 10, 2028
Event
incurrence
Exact text from the filing
On February 10, 2025, Stryker Corporation (the “Company”) completed a public offering (the “Offering”) of $500,000,000 aggregate principal amount of its 4.550% Notes due 2027 (the “2027 Notes”), $700,000,000 aggregate principal amount of its 4.700% Notes due 2028 (the “2028 Notes”), $800,000,000 aggregate principal amount of its 4.850% Notes due 2030 (the “2030 Notes”) and $1,000,000,000 aggregate principal amount of its 5.200% Notes due 2035 (the “2035 Notes” and, together with the 2027 Notes, the 2028 Notes and the 2030 Notes, the “Notes”).
View on SEC.gov
Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

STRYKER CORP incurred senior notes of $500,000,000 with Public at 4.550% maturing February 10, 2027.

Instrument
senior notes
Principal
$500,000,000
Counterparty
Public
Rate
4.550%
Maturity
February 10, 2027
Event
incurrence
Exact text from the filing
On February 10, 2025, Stryker Corporation (the “Company”) completed a public offering (the “Offering”) of $500,000,000 aggregate principal amount of its 4.550% Notes due 2027 (the “2027 Notes”), $700,000,000 aggregate principal amount of its 4.700% Notes due 2028 (the “2028 Notes”), $800,000,000 aggregate principal amount of its 4.850% Notes due 2030 (the “2030 Notes”) and $1,000,000,000 aggregate principal amount of its 5.200% Notes due 2035 (the “2035 Notes” and, together with the 2027 Notes, the 2028 Notes and the 2030 Notes, the “Notes”).
View on SEC.gov

Browse all debt financings →

STRYKER CORP filing history →

Source: SEC EDGAR
accession 0001193125-25-023587
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.